A Case of Ocular Benign Lymphoid Hyperplasia Treated with Bevacizumab Injection
Korean Journal of Ophthalmology
;
: 57-59, 2011.
Article
Dans Anglais
| WPRIM
| ID: wpr-121935
ABSTRACT
We report the first case of ocular benign lymphoid hyperplasia (BLH) treated with subconjunctival injection of bevacizumab (Avastin). A 27-year-old man presented to our clinic with conjunctival masses and limbal neovascularization. An incisional biopsy yielded the diagnosis of BLH. The patient was subsequently given a subconjunctival injection of bevacizumab (1.25 mg / 0.1 mL). The patient did not experience recurrence or malignant metaplasia during the one-year follow-up period. In patients with conjunctival BLH, subconjunctival injection of bevacizumab can be a useful treatment option in patients unable to undergo a surgical procedure due to limbal neovascularization.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
Sujet Principal:
Limbe de la cornée
/
Conjonctive
/
Maladies de la conjonctive
/
Inhibiteurs de l'angiogenèse
/
Injections oculaires
/
Hyperplasie
/
Tissu lymphoïde
/
Anticorps monoclonaux
/
Néovascularisation pathologique
Limites du sujet:
Adulte
/
Humains
/
Mâle
langue:
Anglais
Texte intégral:
Korean Journal of Ophthalmology
Année:
2011
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS